Article Details

Janssen Licenses "Flexible Antibody" Technology from F-star in New Collab

Retrieved on: 2021-10-21 09:23:08

Tags for this article:

Click the tags to see associated articles and topics

Janssen Licenses "Flexible Antibody" Technology from F-star in New Collab. View article details on hiswai:

Excerpt

... such as the one formed with Denmark's Genmab A/S to develop a therapy using monoclonal antibodies, as well as explore several other potential ...

Article found on: www.biospace.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up